clinical trial · NCT05656794
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
University Health Network, Toronto·phase2·recruiting·n = 40
Prostate MetastasesRadiotherapy
brief summary
This is a prospective, randomized phase II trial investigating if radiation treatment delivered every other day for 2 weeks has the same side effects as radiation treatment delivered once weekly for 6 weeks.
started
Aug 9, 2023
primary completion
Aug 1, 2031
completion
Aug 1, 2031
last updated
Mar 23, 2026
official title
Consolidative Prostate Radiotherapy in Patients With Metastatic Prostate Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol